Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
Clinical trial update indicates ongoing recruitment for trilaciclib to prevent chemoradiotherapy-induced myelosuppression in esophageal squa…
-
CLINICAL_TRIALS other · 2024-11-21Clinical Trial Update: Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC [Phase 2]
Phase 2 trial evaluating camrelizumab plus apatinib mesylate and short-course chemotherapy for advanced esophageal cancer is currently recru…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma [NA]
A completed trial from Zhejiang Cancer Hospital evaluating different radiation doses in neoadjuvant chemoradiotherapy for resectable thoraci…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) [Phase 2]
Phase 2 clinical trial evaluating the combination of tislelizumab with chemoradiotherapy for esophageal squamous cell carcinoma; the study i…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Clinical Trial of Esophagectomy for Esophageal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluated esophagectomy as treatment for esophageal squamous cell carcinoma and has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Preoperative Chemoradiotherapy and MK-3475 for Esophageal Squamous Cell Carcinoma (ACTS-29) [Phase 2]
This Phase 2 trial (ACTS-29) evaluating preoperative chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma has complet…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) [Phase 3]
This is a Phase 3 trial (MK-3475-975/KEYNOTE-975) evaluating pembrolizumab versus placebo in combination with chemotherapy and radiotherapy …
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma [EARLY_Phase 1]
An early-phase (Phase 1) trial evaluating IPM514 in Esophageal Squamous Cell Carcinoma to assess safety, tolerability, pharmacokinetics, and…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma [Phase 3]
A Phase 3 clinical trial is evaluating chemoradiation in combination with tislelizumab as first-line therapy for advanced Esophageal Squamou…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）
A clinical trial update for RENMIN-237 focusing on predicting lymph node status in stage T1 Esophageal Squamous Cell Carcinoma.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of dalpiciclib isethionate and pyrotinib maleate for advanced esophageal squamous cell c…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC) [Phase 2]
A Phase 2 clinical trial evaluating Cadonilimab in combination with Anlotinib, followed by radiotherapy, for recurrent or metastatic esophag…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC [Phase 2]
Phase 2 trial evaluating sintilimab plus chemotherapy followed by definitive chemoradiotherapy in locally advanced esophageal squamous cell …
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial in Esophageal Squamous Cell Carcinoma evaluating a neoantigen-loaded dendritic cell vaccine, potentially in combina…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]
A Phase 1 study evaluating MT-8421 as monotherapy and in combination with nivolumab in selected advanced solid tumors has been terminated. T…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant adebrelimab for resectable esophageal squamous cell carcinoma, comparing 2 versus 4 cycles; …
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing Simmitinib to chemotherapy for advanced esophageal squamous cell carcinoma is not yet recruiting. Sponsor: Shanghai …
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma [Phase 2]
Phase 2 trial evaluating BGB-A317 in combination with chemotherapy as first-line treatment for adults with inoperable, locally advanced, or …
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating local therapy for oligorecurrent and oligometastatic esophageal squamous cell carcinoma; status is complet…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. [Phase 3]
A Phase 3 trial is evaluating camrelizumab plus neoadjuvant chemotherapy or chemoradiotherapy against chemoradiotherapy alone in resectable …
-
CLINICAL_TRIALS other · 2024-10-17Clinical Trial Update: Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial investigating fruquintinib in combination with tislelizumab followed by radiotherapy for esophageal squamous cell carcinoma, c…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics [NA]
Clinical trial registry entry describing an ongoing targeted-agent evaluation in digestive cancers in China based on molecular characteristi…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating adjuvant Sintilimab for locally advanced esophageal squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: JAB-3068 Activity in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial update for JAB-3068 in adults with advanced solid tumors, including Esophageal Squamous Cell Carcinoma, No…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 3]
A Phase 3 trial is evaluating LY01015 plus chemotherapy versus Opdivo plus chemotherapy in advanced or metastatic esophageal squamous cell c…